Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for LV Remodeling in Acute MI
NCT04783870Phase 4Unknown
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Mar 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in myocardial infarction (MI) comparing Dapagliflozin Arm with Placebo Arm (2 arms). Primary endpoint: Left ventricular remodeling at 6 months. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04783870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04783870.